Observational studyDigestive diseases and sciences2024

Efficacy and Safety of GLP-1 Agonists on Metabolic Parameters in Non-diabetic Patients with Inflammatory Bowel Disease.

Joëlle St-Pierre et al.PubMed ↗Publisher ↗

No numbers read from the abstract.